A quarterly CRO review is a structured assessment of your experimentation program's health and impact β measuring whether conversion rates are improving, whether your program is running at the right velocity, and what the testing results so far tell you about where to focus next. Done well, a quarterly review keeps leadership informed, adjusts priorities based on real data, and ensures the program continues to compound value throughout the year. Done poorly (or skipped), it leaves your program running on autopilot without accountability.
What a Quarterly CRO Review Covers
A quarterly review has three components:
- Conversion performance: How are your core CVR metrics trending?
- Program performance: How healthy is your testing program (velocity, win rate, impact)?
- Forward planning: Based on Q results, what should Q+1 prioritize?
The review should take 2β3 hours total, produce a one-page leadership summary, and drive concrete decisions about Q+1 priorities.
Pull these metrics for the quarter and compare to:
- The same quarter last year (year-over-year)
- The previous quarter (quarter-over-quarter)
- Your annual CRO plan targets
Core CVR Metrics
Overall store conversion rate:
Your primary indicator. Calculate as: total orders / total sessions Γ 100.
Watch for: QoQ trends and seasonal patterns. Q4 CVR may naturally be higher due to Diwali traffic; comparing to Q4 last year is more meaningful than comparing to Q3.
Mobile CVR:
Separate from overall because mobile conversion typically runs 30β50% below desktop. If your mobile CVR is improving relative to desktop, your mobile UX optimizations are working.
New visitor CVR vs. returning visitor CVR:
If your new visitor CVR is dropping, it may indicate acquisition traffic quality changes rather than site issues. If returning visitor CVR is dropping, look at retention and product satisfaction.
CVR by traffic source:
- Organic search CVR
- Paid search CVR
- Social traffic CVR
- Email traffic CVR
- Direct traffic CVR
Traffic source CVR shifts often reveal marketing mix changes or quality shifts, not site optimization issues.
Funnel Stage Drop-Offs
Track the conversion rate at each funnel stage:
| Stage | Q metric | QoQ change | YoY change |
|---|
| Landing β Category | X% | +/-Y% | +/-Z% |
| Category β PDP | X% | +/-Y% | +/-Z% |
| PDP β Add to Cart | X% | +/-Y% | +/-Z% |
| Add to Cart β Checkout | X% | +/-Y% | +/-Z% |
| Checkout β Purchase | X% | +/-Y% | +/-Z% |
A stage that's declining while others hold steady is your optimization priority for Q+1.
Supporting Metrics
- Average order value (AOV): Is it trending up from cross-sell and upsell tests?
- Cart abandonment rate: Directly affected by cart and checkout optimizations
- Bounce rate on key pages: Homepage, hero PDPs, category pages
- Session duration: Are buyers engaging more deeply with the site?
- Pages per session: More pages often indicates better product discovery
Test Velocity
How many tests did you run this quarter?
| Metric | This Quarter | Q-1 | Q1 Target |
|---|
| Tests launched | N | N | N |
| Tests completed | N | N | N |
| Tests per month | N | N | N |
If velocity is below target, diagnose the bottleneck:
- Hypothesis backlog empty? β Build your hypothesis library
- Design bottleneck? β Simplify variant creation or hire design support
- Developer dependency? β Switch to no-code testing with CustomFit.ai
- Leadership support issues? β Review your CRO business case presentation
Win Rate and Result Quality
| Metric | This Quarter | Full Year |
|---|
| Tests with statistically significant results | N | N |
| Win rate (% producing significant improvements) | X% | X% |
| Average CVR lift from winning tests | X% | X% |
| Tests shipped to production | N | N |
A healthy win rate is 25β40%. If your win rate is below 20%, your hypotheses may not be evidence-based enough. Above 50% may indicate tests are being called before statistical significance.
Revenue Impact Estimate
For each test winner you shipped this quarter, calculate estimated annual revenue impact:
Formula:
Estimated annual revenue impact = (variant CVR - control CVR) Γ monthly sessions on that page Γ AOV Γ 12
Example:
- Test: New CTA copy on hero PDP
- Control CVR: 3.2%, Variant CVR: 3.7% (0.5pp improvement)
- Monthly sessions: 15,000
- AOV: βΉ1,400
- Estimated annual impact: 0.005 Γ 15,000 Γ 1,400 Γ 12 = βΉ12.6 lakh
Total the impact estimates for all Q winners. This is your quarterly CRO ROI estimate.
Note the caveats: These are estimates. They assume consistent traffic, stable conversion environment, and no interaction effects from other changes. Present them with appropriate context but don't over-hedge β leadership needs a number to evaluate the program.
Hypothesis Library Health
- How many hypotheses are in your backlog?
- How many are "ready to test" (fully written with evidence)?
- How many are "needs evidence" (ideas without supporting data)?
A healthy hypothesis library should always have 4β6 weeks of ready-to-test hypotheses.
Component 3: Q+1 Planning
Key Learnings from the Quarter
Synthesize 3β5 key learnings from this quarter's test results. Not just "this test won" β but what did it teach you about your buyers?
Examples:
- "Urgency messaging consistently loses on our PDP. Our buyers appear to be high-consideration, and urgency may undermine trust rather than accelerate decisions."
- "Mobile add-to-cart rate improved 18% by moving the CTA above the product description. Mobile image-first presentation correlates with lower intent β buyers need to see the CTA sooner."
- "Price tests showed buyers are relatively price-insensitive in the βΉ800ββΉ1,500 range. Three tests in this range showed no significant impact from 10% price variation."
These learnings shape hypothesis quality for Q+1.
Updated Priorities for Q+1
Based on funnel analysis and test learnings:
- Which funnel stage needs the most attention this quarter?
- Which high-priority hypotheses from the backlog should run first?
- Are there seasonal considerations (upcoming festive period, new collection launch) that should influence test themes?
Resource Check
- Did you have the design and development capacity you needed this quarter?
- Was the testing tool sufficient for the tests you wanted to run?
- Does anything need to change in Q+1 to maintain or increase velocity?
The Quarterly CRO Report for Leadership
The leadership report should be one page. Here's the template:
Q[N] CRO REVIEW β [DATE]
RESULTS SUMMARY:
- Tests launched: [N] | Tests completed: [N]
- Significant improvements found: [N] tests
- Tests shipped: [N]
- Estimated annual revenue impact from Q[N] winners: βΉ[X]
CONVERSION PERFORMANCE:
- Overall CVR: [X]% ([+/-Y]% vs. Q[N-1], [+/-Z]% vs. annual target)
- Mobile CVR: [X]% ([trend])
- Cart abandonment: [X]% ([trend])
PROGRESS VS. ANNUAL GOALS:
- Goal 1: [X]% vs. target [Y]% β [on track / ahead / behind]
- Goal 2: [X]% vs. target [Y]% β [on track / ahead / behind]
TOP 3 LEARNINGS:
1. [Learning from test result]
2. [Learning from test result]
3. [Learning from test result]
Q[N+1] PRIORITIES:
1. [Focus area and rationale]
2. [Focus area and rationale]
3. [Focus area and rationale]
ESTIMATED Q[N+1] TESTS: [N] (velocity target: [N]/month)
This format takes 10 minutes to read, answers leadership's key questions, and drives productive discussion about Q+1 priorities.
Cadence and Meeting Structure
Preparation (1 hour):
Pull all metrics, calculate program impact, update hypothesis library
Internal review (30 minutes):
CRO team or program owner reviews data and drafts key learnings
Leadership presentation (30β45 minutes):
Walk through the one-page report, highlight key learnings, present Q+1 plan, get alignment on resource requests
Post-review (30 minutes):
Update annual CRO plan document, confirm Q+1 hypothesis priorities, adjust testing calendar if needed
Common Mistakes in Quarterly CRO Reviews
Presenting statistics instead of business impact. "Our tests achieved 95% confidence across 12 experiments" means nothing to most stakeholders. "We estimate these test wins will generate βΉ25 lakh in additional annual revenue" is meaningful.
Ignoring losing tests. A review that only covers wins misses half the value. Failed tests often contain the most important learnings for Q+1 hypothesis generation.
Not updating the annual plan. If Q results show you're behind on annual goals, the plan needs to adjust. Carry forward the annual plan unchanged regardless of Q results is management theater, not program management.
Skipping the review when things are going well. The review process is most valuable when the program is working well β it builds the institutional memory that sustains the program through leadership changes and team turnover.
Key Takeaways
- A quarterly CRO review has three components: conversion performance, program health, and Q+1 planning
- The one-page leadership report should lead with estimated revenue impact, not statistical terminology
- Track win rate, test velocity, and estimated revenue impact as your program health KPIs
- Always analyze losing tests β they contain the learnings that improve Q+1 hypotheses
- Update your annual CRO plan based on quarterly results; a static annual plan becomes irrelevant quickly
- The review should drive 3 concrete decisions: Q+1 focus areas, resource adjustments, and hypothesis priorities
experimentation
experimentation
experimentation